Company intelligence / Profile preview

Encore Path

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Encore Path was a medical technology company specializing in the development of rehabilitation devices for stroke survivors. The company's flagship product, the Bilateral Arm Training with Rhythmic Auditory Cueing (BATRAC) device, was designed to facilitate motor recovery in patients with chronic upper-extremity hemiparesis. Based on research conducted at the University of Maryland, the technology utilized repetitive, rhythmic bilateral movements to stimulate neuroplasticity and improve limb coordination. The device was marketed for use in both professional clinical settings and for home-based therapy to support long-term patient recovery.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Encore Path.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Encore Path.

Explore the full profile